 Robert Breeze
Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 18 | 2011 | 334 | 1.160 |
Why?
| | Endolymphatic Hydrops | 2 | 2013 | 3 | 0.950 |
Why?
| | Meniere Disease | 2 | 2013 | 30 | 0.910 |
Why?
| | Fetal Tissue Transplantation | 13 | 2004 | 35 | 0.900 |
Why?
| | Trigeminal Neuralgia | 2 | 2019 | 11 | 0.750 |
Why?
| | Surgical Instruments | 3 | 2019 | 49 | 0.740 |
Why?
| | Microvascular Decompression Surgery | 1 | 2019 | 2 | 0.700 |
Why?
| | Polytetrafluoroethylene | 1 | 2019 | 25 | 0.690 |
Why?
| | Intracranial Aneurysm | 5 | 2018 | 99 | 0.550 |
Why?
| | Brain Tissue Transplantation | 8 | 2004 | 19 | 0.530 |
Why?
| | Cell Transplantation | 2 | 2011 | 39 | 0.500 |
Why?
| | Ear, Inner | 1 | 2013 | 39 | 0.460 |
Why?
| | Dopaminergic Neurons | 1 | 2011 | 43 | 0.390 |
Why?
| | Reperfusion Injury | 1 | 2013 | 276 | 0.390 |
Why?
| | Meningioma | 2 | 2009 | 82 | 0.390 |
Why?
| | Osteochondroma | 1 | 2009 | 7 | 0.370 |
Why?
| | Dura Mater | 1 | 2009 | 29 | 0.360 |
Why?
| | Meningeal Neoplasms | 2 | 2009 | 90 | 0.350 |
Why?
| | Clinical Trials as Topic | 3 | 2011 | 969 | 0.310 |
Why?
| | Bone Neoplasms | 1 | 2009 | 199 | 0.310 |
Why?
| | Mesencephalon | 6 | 2003 | 57 | 0.280 |
Why?
| | Models, Biological | 1 | 2013 | 1715 | 0.280 |
Why?
| | Brain Neoplasms | 5 | 2018 | 1022 | 0.270 |
Why?
| | Radiosurgery | 3 | 2018 | 318 | 0.270 |
Why?
| | Hemangioma, Cavernous | 2 | 2003 | 16 | 0.270 |
Why?
| | Dopamine | 7 | 2009 | 249 | 0.250 |
Why?
| | Craniotomy | 4 | 2019 | 69 | 0.220 |
Why?
| | Mutism | 1 | 2002 | 4 | 0.210 |
Why?
| | Central Nervous System Neoplasms | 1 | 2003 | 128 | 0.210 |
Why?
| | Cerebral Hemorrhage | 1 | 2002 | 100 | 0.200 |
Why?
| | Neurons | 4 | 2003 | 1345 | 0.200 |
Why?
| | Subarachnoid Hemorrhage | 2 | 2018 | 64 | 0.200 |
Why?
| | Brain Stem Neoplasms | 1 | 2002 | 90 | 0.200 |
Why?
| | Humans | 48 | 2019 | 118974 | 0.170 |
Why?
| | Loeys-Dietz Syndrome | 1 | 2018 | 6 | 0.160 |
Why?
| | CTLA-4 Antigen | 1 | 2018 | 86 | 0.160 |
Why?
| | Carotid Artery Injuries | 1 | 1998 | 42 | 0.160 |
Why?
| | Middle Aged | 26 | 2017 | 27617 | 0.150 |
Why?
| | Aneurysm, Ruptured | 1 | 2018 | 38 | 0.150 |
Why?
| | Adult | 23 | 2017 | 31512 | 0.150 |
Why?
| | Choroid Plexus Neoplasms | 1 | 1997 | 9 | 0.150 |
Why?
| | Aged | 17 | 2018 | 19657 | 0.150 |
Why?
| | Papilloma | 1 | 1997 | 46 | 0.150 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2018 | 197 | 0.140 |
Why?
| | Antiparkinson Agents | 5 | 2003 | 26 | 0.140 |
Why?
| | Intracranial Arteriovenous Malformations | 2 | 2009 | 53 | 0.140 |
Why?
| | Antibodies | 1 | 2018 | 392 | 0.140 |
Why?
| | Magnetic Resonance Imaging | 10 | 2009 | 3174 | 0.140 |
Why?
| | Quadriplegia | 1 | 1995 | 11 | 0.140 |
Why?
| | Parietal Bone | 1 | 1995 | 12 | 0.140 |
Why?
| | Bone Cysts | 1 | 1995 | 10 | 0.140 |
Why?
| | Rhabdomyolysis | 1 | 1995 | 18 | 0.130 |
Why?
| | Epidermal Cyst | 1 | 1995 | 12 | 0.130 |
Why?
| | Male | 30 | 2018 | 57801 | 0.130 |
Why?
| | Head Injuries, Closed | 1 | 1995 | 55 | 0.130 |
Why?
| | Levodopa | 3 | 2004 | 23 | 0.130 |
Why?
| | Fibromuscular Dysplasia | 1 | 2014 | 4 | 0.130 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 2014 | 14 | 0.130 |
Why?
| | Wounds, Nonpenetrating | 1 | 1998 | 285 | 0.130 |
Why?
| | Age Factors | 4 | 2013 | 2995 | 0.120 |
Why?
| | Aged, 80 and over | 2 | 2018 | 6561 | 0.120 |
Why?
| | Lymphoma | 2 | 2003 | 180 | 0.120 |
Why?
| | Female | 25 | 2018 | 61565 | 0.120 |
Why?
| | Neurofibromatosis 1 | 1 | 2014 | 37 | 0.120 |
Why?
| | Cerebral Arteries | 1 | 2014 | 56 | 0.120 |
Why?
| | Collagen | 1 | 1996 | 433 | 0.120 |
Why?
| | Brain Diseases | 1 | 1995 | 140 | 0.120 |
Why?
| | Melanoma | 2 | 2018 | 664 | 0.120 |
Why?
| | Audiometry, Evoked Response | 1 | 2013 | 15 | 0.120 |
Why?
| | False Negative Reactions | 1 | 2013 | 57 | 0.120 |
Why?
| | Alleles | 1 | 1996 | 832 | 0.120 |
Why?
| | Autopsy | 1 | 2013 | 89 | 0.120 |
Why?
| | Temporal Bone | 1 | 2013 | 43 | 0.110 |
Why?
| | Treatment Outcome | 10 | 2018 | 9342 | 0.110 |
Why?
| | Pineal Gland | 2 | 1997 | 13 | 0.110 |
Why?
| | Cerebral Ventricles | 2 | 1991 | 48 | 0.110 |
Why?
| | Pressure | 1 | 2013 | 226 | 0.110 |
Why?
| | Double-Blind Method | 7 | 2009 | 1687 | 0.110 |
Why?
| | Chickenpox | 1 | 2013 | 100 | 0.110 |
Why?
| | Spinal Cord Injuries | 1 | 1995 | 184 | 0.110 |
Why?
| | Terminology as Topic | 1 | 2013 | 211 | 0.110 |
Why?
| | Dihydroxyphenylalanine | 2 | 2009 | 7 | 0.100 |
Why?
| | Postoperative Complications | 2 | 2002 | 2235 | 0.100 |
Why?
| | Pseudotumor Cerebri | 1 | 1991 | 22 | 0.100 |
Why?
| | Follow-Up Studies | 8 | 2009 | 4596 | 0.100 |
Why?
| | Data Interpretation, Statistical | 1 | 2013 | 336 | 0.100 |
Why?
| | Intracranial Pressure | 1 | 1991 | 53 | 0.100 |
Why?
| | Tomography, Emission-Computed | 5 | 2003 | 58 | 0.100 |
Why?
| | Nerve Tissue | 1 | 1990 | 8 | 0.100 |
Why?
| | Hydrocephalus | 1 | 1991 | 81 | 0.100 |
Why?
| | Embryonic Stem Cells | 1 | 2011 | 114 | 0.100 |
Why?
| | Skull Neoplasms | 2 | 2003 | 22 | 0.100 |
Why?
| | Spinal Cord Diseases | 1 | 1990 | 39 | 0.100 |
Why?
| | Substantia Nigra | 2 | 2004 | 38 | 0.090 |
Why?
| | Cysts | 1 | 1990 | 93 | 0.090 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 968 | 0.090 |
Why?
| | Herpes Zoster | 1 | 2013 | 336 | 0.090 |
Why?
| | Statistics as Topic | 1 | 2009 | 307 | 0.080 |
Why?
| | Cerebrospinal Fluid | 1 | 1989 | 93 | 0.080 |
Why?
| | Radiopharmaceuticals | 1 | 2009 | 194 | 0.080 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2009 | 190 | 0.080 |
Why?
| | Point Mutation | 1 | 2009 | 228 | 0.080 |
Why?
| | Acute Kidney Injury | 1 | 1995 | 709 | 0.080 |
Why?
| | Microtubule-Associated Proteins | 1 | 2009 | 188 | 0.080 |
Why?
| | Iridium | 1 | 1987 | 6 | 0.080 |
Why?
| | Radioisotopes | 1 | 1987 | 34 | 0.080 |
Why?
| | Pinealoma | 1 | 1987 | 11 | 0.080 |
Why?
| | Encephalitis | 1 | 1989 | 129 | 0.080 |
Why?
| | Fetus | 2 | 1990 | 690 | 0.070 |
Why?
| | Brachytherapy | 1 | 1987 | 103 | 0.070 |
Why?
| | Adolescent | 7 | 2014 | 18480 | 0.070 |
Why?
| | Magnetic Resonance Angiography | 2 | 2018 | 210 | 0.070 |
Why?
| | Disease Progression | 3 | 2018 | 2490 | 0.070 |
Why?
| | Proto-Oncogene Proteins | 1 | 2009 | 618 | 0.070 |
Why?
| | Risk Factors | 2 | 2013 | 9000 | 0.070 |
Why?
| | Glioblastoma | 2 | 2003 | 262 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2017 | 2220 | 0.060 |
Why?
| | Young Adult | 3 | 2017 | 10793 | 0.060 |
Why?
| | Dopamine Agents | 1 | 2004 | 14 | 0.060 |
Why?
| | Incidence | 2 | 2003 | 2424 | 0.060 |
Why?
| | Transplantation | 1 | 2004 | 26 | 0.060 |
Why?
| | Endothelial Cells | 1 | 2009 | 732 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 1868 | 0.060 |
Why?
| | Glioma | 1 | 1987 | 306 | 0.060 |
Why?
| | Cerebral Angiography | 3 | 1998 | 116 | 0.060 |
Why?
| | Transplants | 1 | 2003 | 36 | 0.060 |
Why?
| | Brain | 6 | 2009 | 2490 | 0.060 |
Why?
| | Granuloma, Foreign-Body | 1 | 2003 | 10 | 0.060 |
Why?
| | Membrane Proteins | 1 | 2009 | 1055 | 0.060 |
Why?
| | Transplantation, Heterologous | 1 | 2003 | 194 | 0.060 |
Why?
| | Embryo, Mammalian | 1 | 2003 | 220 | 0.060 |
Why?
| | Reaction Time | 1 | 2004 | 392 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2003 | 310 | 0.050 |
Why?
| | Stem Cell Transplantation | 1 | 2003 | 153 | 0.050 |
Why?
| | Combined Modality Therapy | 4 | 2018 | 1166 | 0.050 |
Why?
| | Dysarthria | 1 | 2002 | 9 | 0.050 |
Why?
| | Cerebellar Nuclei | 1 | 2002 | 11 | 0.050 |
Why?
| | Child, Preschool | 2 | 2013 | 9491 | 0.050 |
Why?
| | Preoperative Care | 1 | 2004 | 332 | 0.050 |
Why?
| | Laminectomy | 2 | 1999 | 26 | 0.050 |
Why?
| | Confidence Intervals | 1 | 2002 | 324 | 0.050 |
Why?
| | Control Groups | 1 | 2001 | 10 | 0.050 |
Why?
| | Thalamus | 1 | 2002 | 80 | 0.050 |
Why?
| | Cholesterol | 1 | 2003 | 373 | 0.050 |
Why?
| | Movement | 3 | 2009 | 248 | 0.050 |
Why?
| | ErbB Receptors | 1 | 2003 | 569 | 0.050 |
Why?
| | Neural Pathways | 1 | 2002 | 277 | 0.050 |
Why?
| | Stereotaxic Techniques | 3 | 1995 | 28 | 0.050 |
Why?
| | Child | 4 | 2018 | 19129 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2009 | 709 | 0.040 |
Why?
| | Spinal Stenosis | 1 | 1999 | 26 | 0.040 |
Why?
| | Placebos | 1 | 2000 | 202 | 0.040 |
Why?
| | Motor Activity | 1 | 2004 | 660 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2003 | 1691 | 0.040 |
Why?
| | Intervertebral Disc Displacement | 1 | 1999 | 39 | 0.040 |
Why?
| | Prospective Studies | 2 | 2002 | 6471 | 0.040 |
Why?
| | Smooth Muscle Tumor | 1 | 1998 | 5 | 0.040 |
Why?
| | Sarcoma, Synovial | 1 | 1998 | 10 | 0.040 |
Why?
| | Leiomyosarcoma | 1 | 1998 | 23 | 0.040 |
Why?
| | Dobutamine | 1 | 1998 | 36 | 0.040 |
Why?
| | Ligation | 1 | 2018 | 82 | 0.040 |
Why?
| | Aortography | 1 | 1998 | 52 | 0.040 |
Why?
| | Genotype | 2 | 2009 | 1882 | 0.040 |
Why?
| | Leiomyoma | 1 | 1998 | 45 | 0.040 |
Why?
| | Blood Volume | 1 | 1998 | 58 | 0.040 |
Why?
| | Lumbar Vertebrae | 1 | 1999 | 215 | 0.040 |
Why?
| | Gene Expression | 1 | 2003 | 1489 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 403 | 0.040 |
Why?
| | Drainage | 1 | 2018 | 157 | 0.040 |
Why?
| | Cell Nucleolus | 1 | 1997 | 17 | 0.040 |
Why?
| | Adrenergic beta-Agonists | 1 | 1998 | 132 | 0.040 |
Why?
| | Inclusion Bodies | 1 | 1997 | 25 | 0.040 |
Why?
| | Animals | 5 | 2011 | 33381 | 0.040 |
Why?
| | Blotting, Southern | 1 | 1996 | 67 | 0.040 |
Why?
| | DNA Probes | 1 | 1996 | 60 | 0.040 |
Why?
| | Carotid Arteries | 1 | 1998 | 184 | 0.040 |
Why?
| | Postoperative Care | 1 | 2018 | 237 | 0.040 |
Why?
| | Prevalence | 1 | 2002 | 2326 | 0.030 |
Why?
| | Cytoplasm | 1 | 1997 | 269 | 0.030 |
Why?
| | Putamen | 4 | 2003 | 14 | 0.030 |
Why?
| | Cerebrovascular Circulation | 1 | 1998 | 204 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2018 | 12978 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 3 | 1995 | 2436 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2017 | 544 | 0.030 |
Why?
| | Aorta, Thoracic | 1 | 1998 | 248 | 0.030 |
Why?
| | Immobilization | 1 | 1995 | 47 | 0.030 |
Why?
| | Vision Disorders | 1 | 1997 | 135 | 0.030 |
Why?
| | Micromanipulation | 1 | 1995 | 12 | 0.030 |
Why?
| | Brain Edema | 1 | 1995 | 61 | 0.030 |
Why?
| | Visual Acuity | 1 | 1997 | 272 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2000 | 1244 | 0.030 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 1995 | 158 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2001 | 2674 | 0.030 |
Why?
| | Brain Ischemia | 1 | 1998 | 310 | 0.030 |
Why?
| | Intraoperative Complications | 1 | 1995 | 132 | 0.030 |
Why?
| | Equipment Design | 1 | 1995 | 519 | 0.030 |
Why?
| | Receptors, Dopamine | 1 | 1993 | 13 | 0.030 |
Why?
| | Brain Stem | 2 | 1992 | 104 | 0.030 |
Why?
| | Radiography | 1 | 1995 | 861 | 0.030 |
Why?
| | Nerve Regeneration | 1 | 1993 | 53 | 0.030 |
Why?
| | Body Water | 1 | 1991 | 28 | 0.030 |
Why?
| | Neurologic Examination | 4 | 1993 | 126 | 0.030 |
Why?
| | Acute Disease | 2 | 1998 | 940 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2513 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 1998 | 589 | 0.020 |
Why?
| | Syndrome | 1 | 1991 | 344 | 0.020 |
Why?
| | Adrenal Glands | 1 | 1990 | 72 | 0.020 |
Why?
| | Neostriatum | 1 | 2009 | 30 | 0.020 |
Why?
| | KRIT1 Protein | 1 | 2009 | 6 | 0.020 |
Why?
| | Corpus Striatum | 1 | 1990 | 127 | 0.020 |
Why?
| | Escherichia coli Infections | 1 | 1989 | 105 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 381 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 1988 | 154 | 0.020 |
Why?
| | Positron-Emission Tomography | 1 | 2009 | 298 | 0.020 |
Why?
| | Caudate Nucleus | 3 | 1993 | 16 | 0.020 |
Why?
| | Gene Frequency | 1 | 2009 | 513 | 0.020 |
Why?
| | Rabbits | 1 | 1989 | 780 | 0.020 |
Why?
| | Quality of Life | 1 | 1998 | 2366 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1992 | 1945 | 0.020 |
Why?
| | Pituitary Neoplasms | 1 | 1988 | 165 | 0.020 |
Why?
| | Time Factors | 4 | 1999 | 6412 | 0.020 |
Why?
| | Sex Factors | 1 | 2009 | 1781 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 1988 | 597 | 0.020 |
Why?
| | Trigeminal Nerve | 1 | 1982 | 28 | 0.010 |
Why?
| | Corpus Callosum | 1 | 2003 | 57 | 0.010 |
Why?
| | Temporal Arteries | 1 | 2003 | 47 | 0.010 |
Why?
| | Temporal Lobe | 1 | 2003 | 90 | 0.010 |
Why?
| | Treatment Failure | 1 | 2003 | 341 | 0.010 |
Why?
| | Rats | 1 | 1990 | 5392 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2003 | 148 | 0.010 |
Why?
| | Psychomotor Performance | 1 | 2004 | 290 | 0.010 |
Why?
| | Walking | 2 | 1999 | 415 | 0.010 |
Why?
| | Fluorine Radioisotopes | 1 | 2001 | 11 | 0.010 |
Why?
| | Culture Techniques | 1 | 2001 | 80 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 770 | 0.010 |
Why?
| | Down-Regulation | 1 | 2003 | 627 | 0.010 |
Why?
| | Reoperation | 1 | 1982 | 557 | 0.010 |
Why?
| | Work | 1 | 1999 | 18 | 0.010 |
Why?
| | Vascular Surgical Procedures | 1 | 1982 | 262 | 0.010 |
Why?
| | Recurrence | 1 | 1982 | 975 | 0.010 |
Why?
| | Ethics, Medical | 1 | 2000 | 73 | 0.010 |
Why?
| | Lumbosacral Region | 1 | 1999 | 50 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 872 | 0.010 |
Why?
| | Stem Cells | 1 | 2003 | 559 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2003 | 1032 | 0.010 |
Why?
| | Sella Turcica | 1 | 1998 | 12 | 0.010 |
Why?
| | Biomarkers | 1 | 1988 | 3588 | 0.010 |
Why?
| | Tumor Virus Infections | 1 | 1998 | 41 | 0.010 |
Why?
| | Low Back Pain | 1 | 1999 | 100 | 0.010 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 1998 | 75 | 0.010 |
Why?
| | Herpesvirus 4, Human | 1 | 1998 | 126 | 0.010 |
Why?
| | Fatal Outcome | 1 | 1998 | 287 | 0.010 |
Why?
| | Risk | 1 | 2000 | 853 | 0.010 |
Why?
| | Pain | 1 | 1982 | 735 | 0.010 |
Why?
| | Herpesviridae Infections | 1 | 1998 | 142 | 0.010 |
Why?
| | Spinal Fusion | 1 | 1999 | 225 | 0.010 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1998 | 224 | 0.010 |
Why?
| | Arteries | 1 | 1997 | 250 | 0.010 |
Why?
| | Antibody-Dependent Cell Cytotoxicity | 1 | 1995 | 20 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2003 | 2657 | 0.010 |
Why?
| | Muscle Contraction | 1 | 1998 | 413 | 0.010 |
Why?
| | Length of Stay | 1 | 1999 | 1032 | 0.010 |
Why?
| | Vasodilation | 1 | 1998 | 457 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1995 | 204 | 0.010 |
Why?
| | RNA, Viral | 1 | 1998 | 572 | 0.010 |
Why?
| | Cyclosporine | 1 | 1995 | 173 | 0.010 |
Why?
| | Primates | 1 | 1995 | 114 | 0.010 |
Why?
| | Prednisone | 1 | 1995 | 235 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 1995 | 415 | 0.010 |
Why?
| | Antibody Formation | 1 | 1995 | 276 | 0.010 |
Why?
| | Tissue Survival | 1 | 1992 | 13 | 0.010 |
Why?
| | Immunity, Cellular | 1 | 1995 | 270 | 0.010 |
Why?
| | Dominance, Cerebral | 1 | 1993 | 53 | 0.010 |
Why?
| | Spleen | 1 | 1995 | 510 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 1997 | 1795 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1995 | 455 | 0.010 |
Why?
| | Video Recording | 1 | 1992 | 156 | 0.010 |
Why?
| | Spinal Cord | 1 | 1992 | 367 | 0.010 |
Why?
| | Activities of Daily Living | 1 | 1992 | 354 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1990 | 182 | 0.010 |
Why?
| | Motor Skills | 1 | 1990 | 85 | 0.010 |
Why?
| | Cell Line | 1 | 1995 | 2707 | 0.010 |
Why?
| | Antigens, Nuclear | 1 | 1988 | 18 | 0.010 |
Why?
| | Aneuploidy | 1 | 1988 | 88 | 0.000 |
Why?
| | Pituitary Gland | 1 | 1988 | 163 | 0.000 |
Why?
| | Fluorescent Antibody Technique | 1 | 1988 | 410 | 0.000 |
Why?
| | Cell Cycle | 1 | 1988 | 550 | 0.000 |
Why?
| | Flow Cytometry | 1 | 1988 | 1085 | 0.000 |
Why?
|
|
Breeze's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|